| 000 | 01605 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516211525.0 | ||
| 264 | 0 | _c20150511 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1477-0962 | ||
| 024 | 7 |
_a10.1177/0961203314532699 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPetri, M | |
| 245 | 0 | 0 |
_aBurden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel. _h[electronic resource] |
| 260 |
_bLupus _cSep 2014 |
||
| 300 |
_a1006-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
| 650 | 0 | 4 | _aConsensus |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDelphi Technique |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xeconomics |
| 650 | 0 | 4 | _aHealth Care Surveys |
| 650 | 0 | 4 |
_aHealth Resources _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xdiagnosis |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aTelecommunications |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aBechtel, B | |
| 700 | 1 | _aDennis, G | |
| 700 | 1 | _aShah, M | |
| 700 | 1 | _aMcLaughlin, T | |
| 700 | 1 | _aKan, H | |
| 700 | 1 | _aMolta, C | |
| 773 | 0 |
_tLupus _gvol. 23 _gno. 10 _gp. 1006-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0961203314532699 _zAvailable from publisher's website |
| 999 |
_c23786761 _d23786761 |
||